Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 222-583-2 | CAS number: 3542-36-7
Endpoint summary
Administrative data
Description of key information
Appel & Waalkens-Berends, 2004, was chosen as the key study as it was awarded a reliability score of 1 and was the only sub-chronic study available. The study was performed to GLP standards and according to the OECD 408 test guideline.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- LOAEL
- 0.7 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
Additional information
Appel & Waalkens-Berends, 2004, was conducted under GLP conditions and in acordance with OECD Guideline 408. Testing was performed with doses of 0, 10, 100 and 300 mg/kg (nominal) in diet. The purity of the test substance was determined as 92.1%, with analytical determinations of actual test concentrations used. No NOEC value was obtained due to decreases in the absolute and relative thymus weights of females of all test concentrations. Although no histopathological changes were noted in the lowest test group to accompany the thymus weight decreases, the effects were considered to be dose-response related and therefore no NOEC value could be determined.
Penninks & Seinen, 1982, reported adverse effects at 50 and 150ppm (nominal in diet) when tested on males.
Kim, 2004, reported BMDL50 of 0.45 mg/kg bw/day on males with doses of 10, 100 and 300 ppm (nominal in diet).
Repeated dose toxicity: via oral route - systemic effects (target organ) cardiovascular / hematological: thymus
Justification for classification or non-classification
According to the criteria of 67/548/EEC or EC Regulation 1272/2008, the substance should be classified as T(Toxic) R48/25 (Danger of serious damage to health by prolonged exposure, Toxic if swallowed) and STOT RE 1 H372 (Causes damage to organs (state all organs affected, if known) through prolonged or repeated exposure (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)) with the signal word "Danger". This corresponds to the classification previously assigned, as listed in Annex I (of the 1st ATP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
